Listed

Core Laboratories Inc.

CLBNYSECIK 1958086EnergyFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$124.6mRevenue, Q2 FY2026, three months to 2026-06-30$124.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001193125-26-326345.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Jul 30, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$124.6mRevenue, Q2 FY2026, three months to 2026-06-30$124.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001193125-26-326345.Report this figure−4.3% on a year earlier
  • Gross marginnot reported (Gross profit not reported)No year-earlier figure to compare
  • Operating margin7.3%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $9.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001193125-26-326345.Revenue: $124.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001193125-26-326345.Report this figure−4.4 pts on a year earlier
  • Net margin4.8%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $6.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001193125-26-326345.Revenue: $124.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001193125-26-326345.Report this figure−3.4 pts on a year earlier
  • Diluted EPS$0.13Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001193125-26-326345.Report this figure−40.9% on a year earlier
  • Free cash flow$3.1mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $7.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001193125-26-326345. Derived: 6-month figure less the 3-month figure.Capital expenditure: $4.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001193125-26-326345. Derived: 6-month figure less the 3-month figure.Report this figure−70.1% on a year earlier

Last eight quarters

Full statements
Revenue$124.6mOperating margin 7.3%
Diluted EPS$0.13, Q2 FY2026
Free cash flow$3.1m, Q2 FY2026
Core Laboratories Inc., key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m134Revenue, Q3 FY2024, three months to 2024-09-30$134.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-23, accession 0001193125-25-248736.Report this figure129Revenue, Q4 FY2024, three months to 2024-12-31$129.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-23, accession 0001193125-26-118177. Derived: 12-month figure less the 9-month figure.Report this figure124Revenue, Q1 FY2025, three months to 2025-03-31$123.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0001193125-26-198109.Report this figure130Revenue, Q2 FY2025, three months to 2025-06-30$130.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001193125-26-326345.Report this figure135Revenue, Q3 FY2025, three months to 2025-09-30$134.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-23, accession 0001193125-25-248736.Report this figure138Revenue, Q4 FY2025, three months to 2025-12-31$138.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-23, accession 0001193125-26-118177. Derived: 12-month figure less the 9-month figure.Report this figure122Revenue, Q1 FY2026, three months to 2026-03-31$121.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0001193125-26-198109.Report this figure125Revenue, Q2 FY2026, three months to 2026-06-30$124.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001193125-26-326345.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%14.7%Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: $19.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-23, accession 0001193125-25-248736.Revenue: $134.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-23, accession 0001193125-25-248736.Report this figure11.0%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $14.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-118177. Derived: 12-month figure less the 9-month figure.Revenue: $129.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-23, accession 0001193125-26-118177. Derived: 12-month figure less the 9-month figure.Report this figure3.6%Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $4.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-01, accession 0001193125-26-198109.Revenue: $123.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0001193125-26-198109.Report this figure11.7%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $15.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001193125-26-326345.Revenue: $130.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001193125-26-326345.Report this figure15.6%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $20.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-23, accession 0001193125-25-248736.Revenue: $134.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-23, accession 0001193125-25-248736.Report this figure11.5%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $15.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-118177. Derived: 12-month figure less the 9-month figure.Revenue: $138.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-23, accession 0001193125-26-118177. Derived: 12-month figure less the 9-month figure.Report this figure1.5%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-01, accession 0001193125-26-198109.Revenue: $121.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0001193125-26-198109.Report this figure7.3%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $9.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001193125-26-326345.Revenue: $124.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001193125-26-326345.Report this figure
Net margin%8.7%Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: $11.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-23, accession 0001193125-25-248736.Revenue: $134.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-23, accession 0001193125-25-248736.Report this figure5.7%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $7.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-118177. Derived: 12-month figure less the 9-month figure.Revenue: $129.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-23, accession 0001193125-26-118177. Derived: 12-month figure less the 9-month figure.Report this figure(0.1%)Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: −$154.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-01, accession 0001193125-26-198109.Revenue: $123.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0001193125-26-198109.Report this figure8.2%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $10.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001193125-26-326345.Revenue: $130.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001193125-26-326345.Report this figure10.6%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $14.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-23, accession 0001193125-25-248736.Revenue: $134.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-23, accession 0001193125-25-248736.Report this figure3.6%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $4.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-118177. Derived: 12-month figure less the 9-month figure.Revenue: $138.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-23, accession 0001193125-26-118177. Derived: 12-month figure less the 9-month figure.Report this figure(0.6%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$789.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-01, accession 0001193125-26-198109.Revenue: $121.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0001193125-26-198109.Report this figure4.8%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $6.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001193125-26-326345.Revenue: $124.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001193125-26-326345.Report this figure
Diluted EPS$ per share0.25Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-23, accession 0001193125-25-248736.Report this figurenot reported (Diluted EPS not reported)0.00Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-01, accession 0001193125-26-198109.Report this figure0.22Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001193125-26-326345.Report this figure0.30Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-23, accession 0001193125-25-248736.Report this figurenot reported (Diluted EPS not reported)(0.02)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-01, accession 0001193125-26-198109.Report this figure0.13Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001193125-26-326345.Report this figure
Free cash flow$m10.4Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $13.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-23, accession 0001193125-25-248736. Derived: 9-month figure less the 6-month figure.Capital expenditure: $2.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-23, accession 0001193125-25-248736. Derived: 9-month figure less the 6-month figure.Report this figure17.4Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $20.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-23, accession 0001193125-26-118177. Derived: 12-month figure less the 9-month figure.Capital expenditure: $3.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-23, accession 0001193125-26-118177. Derived: 12-month figure less the 9-month figure.Report this figure3.9Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $6.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-01, accession 0001193125-26-198109.Capital expenditure: $2.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-01, accession 0001193125-26-198109.Report this figure10.4Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $13.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001193125-26-326345. Derived: 6-month figure less the 3-month figure.Capital expenditure: $3.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001193125-26-326345. Derived: 6-month figure less the 3-month figure.Report this figure6.5Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $8.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-23, accession 0001193125-25-248736. Derived: 9-month figure less the 6-month figure.Capital expenditure: $2.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-23, accession 0001193125-25-248736. Derived: 9-month figure less the 6-month figure.Report this figure5.0Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $7.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-23, accession 0001193125-26-118177. Derived: 12-month figure less the 9-month figure.Capital expenditure: $2.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-23, accession 0001193125-26-118177. Derived: 12-month figure less the 9-month figure.Report this figure0.5Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-01, accession 0001193125-26-198109.Capital expenditure: $3.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-01, accession 0001193125-26-198109.Report this figure3.1Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $7.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001193125-26-326345. Derived: 6-month figure less the 3-month figure.Capital expenditure: $4.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001193125-26-326345. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$526.5mOperating margin 10.7%
Diluted EPS$0.63, FY2025
Free cash flow$25.8m, FY2025
Core Laboratories Inc., key figures for the last five fiscal years
Line itemUnitFY2021-12-31FY2022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m470Revenue, period not labelled, twelve months to 2021-12-31$470.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-15, accession 0000950170-24-015483.Report this figure490Revenue, period not labelled, twelve months to 2022-12-31$489.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-13, accession 0000950170-25-019072.Report this figure510Revenue, FY2023, twelve months to 2023-12-31$509.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-23, accession 0001193125-26-118177.Report this figure524Revenue, FY2024, twelve months to 2024-12-31$523.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-23, accession 0001193125-26-118177.Report this figure527Revenue, FY2025, twelve months to 2025-12-31$526.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-23, accession 0001193125-26-118177.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%9.6%Operating margin, period not labelled, twelve months to 2021-12-31. operating income / revenueOperating income: $45.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-15, accession 0000950170-24-015483.Revenue: $470.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-15, accession 0000950170-24-015483.Report this figure8.5%Operating margin, period not labelled, twelve months to 2022-12-31. operating income / revenueOperating income: $41.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-13, accession 0000950170-25-019072.Revenue: $489.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-13, accession 0000950170-25-019072.Report this figure10.7%Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: $54.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-118177.Revenue: $509.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-23, accession 0001193125-26-118177.Report this figure11.2%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $58.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-118177.Revenue: $523.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-23, accession 0001193125-26-118177.Report this figure10.7%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $56.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-118177.Revenue: $526.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-23, accession 0001193125-26-118177.Report this figure
Net margin%4.2%Net margin, period not labelled, twelve months to 2021-12-31. net income / revenueNet income: $19.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-15, accession 0000950170-24-015483.Revenue: $470.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-15, accession 0000950170-24-015483.Report this figure4.0%Net margin, period not labelled, twelve months to 2022-12-31. net income / revenueNet income: $19.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-13, accession 0000950170-25-019072.Revenue: $489.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-13, accession 0000950170-25-019072.Report this figure7.2%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $36.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-118177.Revenue: $509.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-23, accession 0001193125-26-118177.Report this figure6.0%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $31.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-118177.Revenue: $523.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-23, accession 0001193125-26-118177.Report this figure5.6%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $29.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-118177.Revenue: $526.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-23, accession 0001193125-26-118177.Report this figure
Diluted EPS$ per share0.42Diluted EPS, period not labelled, twelve months to 2021-12-31$0.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-15, accession 0000950170-24-015483.Report this figure0.42Diluted EPS, period not labelled, twelve months to 2022-12-31$0.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-13, accession 0000950170-25-019072.Report this figure0.77Diluted EPS, FY2023, twelve months to 2023-12-31$0.77 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-23, accession 0001193125-26-118177.Report this figure0.66Diluted EPS, FY2024, twelve months to 2024-12-31$0.66 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-23, accession 0001193125-26-118177.Report this figure0.63Diluted EPS, FY2025, twelve months to 2025-12-31$0.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-23, accession 0001193125-26-118177.Report this figure
Free cash flow$m23.0Free cash flow, period not labelled, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $36.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-15, accession 0000950170-24-015483.Capital expenditure: $13.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-15, accession 0000950170-24-015483.Report this figure14.7Free cash flow, period not labelled, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $25.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-13, accession 0000950170-25-019072.Capital expenditure: $10.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-13, accession 0000950170-25-019072.Report this figure14.2Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $24.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-23, accession 0001193125-26-118177.Capital expenditure: $10.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-23, accession 0001193125-26-118177.Report this figure44.5Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $56.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-23, accession 0001193125-26-118177.Capital expenditure: $11.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-23, accession 0001193125-26-118177.Report this figure25.8Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $37.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-23, accession 0001193125-26-118177.Capital expenditure: $11.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-23, accession 0001193125-26-118177.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Core Laboratories Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
ARIEL INVESTMENTS, LLC2026-06-30$164.0m14,074,945Added+904,557
BlackRock, Inc.2026-06-30$86.9m7,460,118Added+251,615
DISCIPLINED GROWTH INVESTORS INC /MN2026-06-30$35.4m3,042,177Reduced−1,894,938
EARNEST PARTNERS LLC2026-06-30$34.3m2,941,004Reduced−114,992
STATE STREET CORP2026-06-30$25.4m2,176,480Added+115,943
CWA Asset Management Group, LLC2026-06-30$20.4m1,755,085Added+14,084
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$18.5m1,590,521Reduced−29,342
DIMENSIONAL FUND ADVISORS LP2026-06-30$18.0m1,548,203Added+195,874
SCHRODER INVESTMENT MANAGEMENT GROUP2026-06-30$16.9m1,543,638New+1,543,638
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$14.9m1,275,421Added+20,585

Recent filings

All 182 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Core Laboratories Inc., recent filings
FiledFormWhat it isAccession number
2026-08-2520:51 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-26-365271
2026-07-3021:13 ET10-QQuarterly reportPeriod 2026-06-300001193125-26-326345
2026-07-2920:43 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-324101
2026-05-1320:54 ET8-K5.07 Shareholder vote results0001193125-26-221857
2026-05-0122:03 ET10-QQuarterly reportPeriod 2026-03-310001193125-26-198109
2026-04-2920:43 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-192018
2026-03-3121:21 ETDEF 14AProxy statementPeriod 2026-03-310001193125-26-134986
2026-03-2320:59 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-119934
2026-03-2301:54 ET10-KAnnual reportPeriod 2025-12-310001193125-26-118177
2026-03-1710:15 ET8-K/A2.02 Results of operations0001193125-26-109251

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 23, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1958086
Tickers
CLB
Exchange
NYSE
SIC code
1389 Oil & Gas Field Services, NEC
Sector
Energy
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Large accelerated filer
Former names
Core Laboratories Luxembourg S.A. (to 2023-02-28)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. Listed shows no prices and gives no investment advice.